Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: A randomized, blinded, phase 3 trial

Jacques P. Brown, Richard L. Prince, Chad Deal, Robert R. Recker, Douglas P. Kiel, Luiz H. De Gregorio, Peyman Hadji, Lorenz C. Hofbauer, Jose M. Álvaro-Gracia, Huei Wang, Matthew Austin, Rachel B. Wagman, Richard Newmark, Cesar Libanati, Javier San Martin, Henry G. Bone

Research output: Contribution to journalArticlepeer-review

454 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: A randomized, blinded, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences